DR. ANDREW F STEWART, MD
Medical Practice in Pittsburgh, PA
License number
Pennsylvania MD063932L
Category
Medical Practice
Type
Specialist
Address
Address
3601 Ave Falk Clinic SUITE 2B, Pittsburgh, PA 15213
Phone
(412) 383-8700
Personal information
See more information about ANDREW F STEWART at radaris.comName
Address
Phone
4 Sunridge Dr, Champion, PA 15622
54 Tullygarron Farm Ln, Bernville, PA 19506
5427 Forbes Ave, Pittsburgh, PA 15217
3787 Bakerstown Rd, Gibsonia, PA 15044
36 Oak Ln, Havertown, PA 19083
Professional information
Ceo Of Virtualcollegefairs.com
Position:
Founder & CEO at Virtualcollegefairs.com
Location:
Greater Pittsburgh Area
Industry:
Education Management
Work:
Virtualcollegefairs.com
since Jan 2008
-
Founder & CEO
Hefren-Tillotson
2006 - 2008
-
Jr. Research Analyst
Education:
Grove City College 2002 - 2006
Bachelors, Finance, Entrepreneurship, Computer Programming
Bachelors, Finance, Entrepreneurship, Computer Programming
Dr. Andrew F Stewart, Pittsburgh PA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
UPMC Oakland Endocrinology
3601 5Th Ave SUITE 3B, Pittsburgh 15213
(412) 586-9700 (Phone)
3601 5Th Ave SUITE 3B, Pittsburgh 15213
(412) 586-9700 (Phone)
Certifications:
Internal Medicine, 1977
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UPMC Oakland Endocrinology
3601 5Th Ave SUITE 3B, Pittsburgh 15213
Upmc Presbyterian Shadyside
200 Lothrop St, Pittsburgh 15213
3601 5Th Ave SUITE 3B, Pittsburgh 15213
Upmc Presbyterian Shadyside
200 Lothrop St, Pittsburgh 15213
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1974
St Lukes-Roosevelt Hospital Center At Roosevelt Division
New Haven Hosp
Columbia University / College of Physicians And Surgeons
Graduated: 1974
St Lukes-Roosevelt Hospital Center At Roosevelt Division
New Haven Hosp
Andrew Fyfe Stewart, Pittsburgh PA
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism
Work:
Univ. of Pittsburgh Physicians
200 Lothrop St, Pittsburgh, PA 15213 Falk Clinic
3601 5Th Ave, Pittsburgh, PA 15213 Univ. of Pittsburgh Physicians
3347 Forbes Ave, Pittsburgh, PA 15213
200 Lothrop St, Pittsburgh, PA 15213 Falk Clinic
3601 5Th Ave, Pittsburgh, PA 15213 Univ. of Pittsburgh Physicians
3347 Forbes Ave, Pittsburgh, PA 15213
Education:
Columbia University (1974)
Partner At Silk And Stewart
Position:
Partner at Silk and Stewart
Location:
Greater Pittsburgh Area
Industry:
Real Estate
Work:
Silk and Stewart
since 1988
-
Partner
Education:
Franklin & Marshall College 1979 - 1982
Pthrp-Derived Modulators Of Smooth Muscle Proliferation
US Patent:
2005026, Nov 24, 2005
Filed:
Feb 15, 2005
Appl. No.:
11/058384
Inventors:
Andrew Stewart - Pittsburgh PA, US
International Classification:
C07K014/635, C07K016/26, C12N007/00, C12N015/09, A61K038/29
US Classification:
514012000, 530399000, 435069400, 435320100, 435325000, 435235100, 530388240
Abstract:
The present invention relates to the use of mutants of parathyroid hormone-related protein, to treat disorders associated with smooth muscle cells, and to inhibit the cellular activation and proliferation thereof. The method can be employed in diverse tissues to effect therapeutic and prophylactic relief for disorders and diseases manifested by activation of smooth muscle that can lead to excessive smooth muscle proliferation. For example, where employed in the vasculature, the inventive method can be used to treat restenosis following angioplasty.
Treatment Of Bone Disorders With Skeletal Anabolic Drugs
US Patent:
7384912, Jun 10, 2008
Filed:
Aug 31, 2005
Appl. No.:
11/216511
Inventors:
Andrew F. Stewart - Pittsburgh PA, US
Assignee:
Osteotrophin, LLC - Pittsburgh PA
International Classification:
A61K 38/29, C07K 14/635
US Classification:
514 2, 514 12, 530324
Abstract:
Disclosed herein are methods for the prevention and treatment of a variety of mammalian conditions manifested by loss of bone mass, including osteoporosis. The present invention provides methods of using PTHrP, or analogs thereof, for the treatment of metabolic bone disorders that are both effective and have an increased safety.
Treatment Of Bone Disorders With Skeletal Anabolic Drugs
US Patent:
7015195, Mar 21, 2006
Filed:
Jan 10, 2003
Appl. No.:
10/340484
Inventors:
Andrew F. Stewart - Pittsburgh PA, US
Assignee:
Osteotrophin, LLC - Pittsburgh PA
International Classification:
A61K 38/29, C07K 14/635
US Classification:
514 2, 514 12, 530324
Abstract:
Disclosed herein are methods for the prevention and treatment of a variety of mammalian conditions manifested by loss of bone mass, including osteoporosis. The present invention provides methods of using PTHrP, or analogs thereof, for the treatment of metabolic bone disorders that are both effective and have an increased safety.
Treatment Of Bone Disorders With Skeletal Anabolic Drugs
US Patent:
2008030, Dec 11, 2008
Filed:
Apr 25, 2008
Appl. No.:
12/110118
Inventors:
Andrew F. Stewart - Pittsburgh PA, US
International Classification:
A61K 38/29, A61P 19/00, A61P 19/10
US Classification:
514 12
Abstract:
Disclosed herein are methods for the prevention and treatment of a variety of mammalian conditions manifested by loss of bone mass, including osteoporosis. The present invention provides methods of using PTHrP, or analogs thereof, for the treatment of metabolic bone disorders that are both effective and have an increased safety.
Pthrp-Derived Modulators Of Smooth Muscle Proliferation
US Patent:
2010015, Jun 17, 2010
Filed:
Mar 27, 2009
Appl. No.:
12/412972
Inventors:
Andrew F. STEWART - Pittsburgh PA, US
International Classification:
A61K 38/29, C07K 14/635, C07H 21/04, C12N 15/63, C12N 5/10, C12N 7/01, C07K 16/26, A61K 39/395, A61K 31/7088, C12P 21/00, G01N 33/53, C12Q 1/68, A61K 35/76, G06G 7/58, A61P 21/00
US Classification:
4241331, 530399, 536 2351, 4353201, 435325, 4352351, 514 12, 5303892, 53038824, 5303873, 514 44 R, 435 694, 435 71, 435 6, 436501, 424 932, 703 11
Abstract:
The present invention relates to the use of mutants of parathyroid hormone-related protein, to treat disorders associated with smooth muscle cells, and to inhibit the cellular activation and proliferation thereof. The method can be employed in diverse tissues to effect therapeutic and prophylactic relief for disorders and diseases manifested by activation of smooth muscle that can lead to excessive smooth muscle proliferation. For example, where employed in the vasculature, the inventive method can be used to treat restenosis following angioplasty.